Global Lipid Market Size Study & Forecast, by Product (Triglycerides, Phospholipids, Ionizable Lipids, Sphingolipids, Others), by Application (Pharmaceutical, Food & Beverage, Nutrition & Supplements, Others), by Phase (Clinical, Pre-clinical, Others) and

Global Lipid Market Size Study & Forecast, by Product (Triglycerides, Phospholipids, Ionizable Lipids, Sphingolipids, Others), by Application (Pharmaceutical, Food & Beverage, Nutrition & Supplements, Others), by Phase (Clinical, Pre-clinical, Others) and Regional Analysis, 2023-2030

Global Lipid Market is valued at approximately USD 13.63 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2023-2030. Lipids are a class of organic compounds that are insoluble in water but soluble in organic solvents. They play crucial roles in various biological processes and are essential components of cell membranes, energy storage, and signaling molecules. Lipids are characterized by their hydrophobic nature, because they repel water, and are composed of carbon, hydrogen, and oxygen atoms. Examples of lipids include fats, oils, phospholipids, steroids, and waxes. Lipids are considered as an essential ingredient in the production of dietary supplements due to their high energy and fat-soluble vitamin contents. The growth of the global lipids market is driven by advancements in lipid-based drug delivery technologies and the integration of drug formulations. Furthermore, the increasing prevalence of chronic diseases and the need for rapid drug delivery to patients are key factors propelling the market growth.

The global lipids market is poised for growth in the foreseeable future due to the escalating prevalence of chronic conditions, including cardiovascular diseases, neurological disorders, and other long-term illnesses. The World Health Organization (WHO) reported in 2021, that chronic diseases accounted for approximately 60% of total deaths in 2021, highlighting their significant impact. Moreover, the growth of the lipid market is attributed to its expanding applications in various applications, including pharmaceuticals, food and beverages, and nutrition supplements. The increasing demand for lipids in the development of COVID-19 vaccines is expected to further drive market growth. However, the lipid market faces certain constraints, including the high cost of lipid synthesis and the rising cost of raw materials. Additionally, there are various manufacturing challenges associated with lipid nanoparticle production, which is hindering market growth during the forecast period of 2023-2030

The key regions considered for the Global Lipid Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Asia Pacific dominated the market in 2022. This is attributed owing to the growing demand for dietary supplements, functional food, functional beverages, pharmaceuticals, and other related products in the region. The COVID-19 pandemic has brought about significant shifts in people's lifestyles and priorities, leading to increased health consciousness among consumers in the Asia Pacific region. North America is expected to be a fastest-growing region during the forecast period. Factors such as increasing awareness among individuals about the benefits of lipid, as well as surging demand for dietary supplements and functional foods are propelling the growth of the Lipid market in North America.

Major market player included in this report are:
Evonik Industries AG
Avanti Polar Lipids
Nippon Fine Chemicals Co. Ltd.
Lipoid GmbH
Cargill, Inc.
Archer Daniels Midland Company
Koninklijke DSM N.V.
Kerry Group plc
Nordic Naturals, Inc.
Clover Corp.

Recent Developments in the Market:
In November 2022, BioNTech SE, through its affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd., has entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. to acquire one of its GMP-certified manufacturing facilities. This strategic move by BioNTech aims to bolster its presence in the Asian region as part of its expansion strategy.

In September 2021, ABITEC Corporation, a U.S. ingredients supplier, recently entered into an amended agreement with DKSH, enabling the distribution of its specialty lipids in new markets and regions throughout Europe. This partnership has facilitated the expansion of ABITEC's business across various regions, strengthening its presence in the market.

Global Lipid Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Phase, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Triglycerides
Phospholipids
Ionizable Lipids
Sphingolipids
Others

By Application:
Pharmaceutical
Food & Beverage
Nutrition & Supplements
Others

By Phase:
Clinical
Pre-clinical
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Evonik Industries AG
Avanti Polar Lipids
Nippon Fine Chemicals Co. Ltd.
Lipoid GmbH
Cargill, Inc.
Archer Daniels Midland Company
Koninklijke DSM N.V.
Kerry Group plc
Nordic Naturals, Inc.
Clover Corp.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.